EcoDrugPlus

Ensembl ID : ENSOTSG00005013481
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSOTSG00005039859
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSOTSG00005015682
Gene Symbol: -
Cross references: -
150 Possible Orthologues:

Ensembl ID : ENSOTSG00005013562
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSOTSG00005039844
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSOTSG00005039745
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSOTSG00005009723
Gene Symbol: -
Cross references: -
178 Possible Orthologues:

Ensembl ID : ENSOTSG00005040370
Gene Symbol: -
Cross references: -
262 Possible Orthologues:

Ensembl ID : ENSOTSG00005007191
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSOTSG00005016172
Gene Symbol: -
Cross references: -
179 Possible Orthologues:

Ensembl ID : ENSOTSG00005040481
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSOTSG00005005382
Gene Symbol: -
Cross references: -
240 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).